Cargando…

Effects of oligomer toxicity, fibril toxicity and fibril spreading in synucleinopathies

Protein misfolding is a general hallmark of protein deposition diseases, such as Alzheimer’s disease or Parkinson’s disease, in which different types of aggregated species (oligomers, protofibrils and fibrils) are generated by the cells. Despite widespread interest, the relationship between oligomer...

Descripción completa

Detalles Bibliográficos
Autores principales: Cascella, Roberta, Bigi, Alessandra, Cremades, Nunilo, Cecchi, Cristina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8897347/
https://www.ncbi.nlm.nih.gov/pubmed/35244787
http://dx.doi.org/10.1007/s00018-022-04166-9
_version_ 1784663381416869888
author Cascella, Roberta
Bigi, Alessandra
Cremades, Nunilo
Cecchi, Cristina
author_facet Cascella, Roberta
Bigi, Alessandra
Cremades, Nunilo
Cecchi, Cristina
author_sort Cascella, Roberta
collection PubMed
description Protein misfolding is a general hallmark of protein deposition diseases, such as Alzheimer’s disease or Parkinson’s disease, in which different types of aggregated species (oligomers, protofibrils and fibrils) are generated by the cells. Despite widespread interest, the relationship between oligomers and fibrils in the aggregation process and spreading remains elusive. A large variety of experimental evidences supported the idea that soluble oligomeric species of different proteins might be more toxic than the larger fibrillar forms. Furthermore, the lack of correlation between the presence of the typical pathological inclusions and disease sustained this debate. However, recent data show that the β-sheet core of the α-Synuclein (αSyn) fibrils is unable to establish persistent interactions with the lipid bilayers, but they can release oligomeric species responsible for an immediate dysfunction of the recipient neurons. Reversibly, such oligomeric species could also contribute to pathogenesis via neuron-to-neuron spreading by their direct cell-to-cell transfer or by generating new fibrils, following their neuronal uptake. In this Review, we discuss the various mechanisms of cellular dysfunction caused by αSyn, including oligomer toxicity, fibril toxicity and fibril spreading.
format Online
Article
Text
id pubmed-8897347
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-88973472022-03-08 Effects of oligomer toxicity, fibril toxicity and fibril spreading in synucleinopathies Cascella, Roberta Bigi, Alessandra Cremades, Nunilo Cecchi, Cristina Cell Mol Life Sci Review Protein misfolding is a general hallmark of protein deposition diseases, such as Alzheimer’s disease or Parkinson’s disease, in which different types of aggregated species (oligomers, protofibrils and fibrils) are generated by the cells. Despite widespread interest, the relationship between oligomers and fibrils in the aggregation process and spreading remains elusive. A large variety of experimental evidences supported the idea that soluble oligomeric species of different proteins might be more toxic than the larger fibrillar forms. Furthermore, the lack of correlation between the presence of the typical pathological inclusions and disease sustained this debate. However, recent data show that the β-sheet core of the α-Synuclein (αSyn) fibrils is unable to establish persistent interactions with the lipid bilayers, but they can release oligomeric species responsible for an immediate dysfunction of the recipient neurons. Reversibly, such oligomeric species could also contribute to pathogenesis via neuron-to-neuron spreading by their direct cell-to-cell transfer or by generating new fibrils, following their neuronal uptake. In this Review, we discuss the various mechanisms of cellular dysfunction caused by αSyn, including oligomer toxicity, fibril toxicity and fibril spreading. Springer International Publishing 2022-03-04 2022 /pmc/articles/PMC8897347/ /pubmed/35244787 http://dx.doi.org/10.1007/s00018-022-04166-9 Text en © The Author(s) 2022, corrected publication 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Review
Cascella, Roberta
Bigi, Alessandra
Cremades, Nunilo
Cecchi, Cristina
Effects of oligomer toxicity, fibril toxicity and fibril spreading in synucleinopathies
title Effects of oligomer toxicity, fibril toxicity and fibril spreading in synucleinopathies
title_full Effects of oligomer toxicity, fibril toxicity and fibril spreading in synucleinopathies
title_fullStr Effects of oligomer toxicity, fibril toxicity and fibril spreading in synucleinopathies
title_full_unstemmed Effects of oligomer toxicity, fibril toxicity and fibril spreading in synucleinopathies
title_short Effects of oligomer toxicity, fibril toxicity and fibril spreading in synucleinopathies
title_sort effects of oligomer toxicity, fibril toxicity and fibril spreading in synucleinopathies
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8897347/
https://www.ncbi.nlm.nih.gov/pubmed/35244787
http://dx.doi.org/10.1007/s00018-022-04166-9
work_keys_str_mv AT cascellaroberta effectsofoligomertoxicityfibriltoxicityandfibrilspreadinginsynucleinopathies
AT bigialessandra effectsofoligomertoxicityfibriltoxicityandfibrilspreadinginsynucleinopathies
AT cremadesnunilo effectsofoligomertoxicityfibriltoxicityandfibrilspreadinginsynucleinopathies
AT cecchicristina effectsofoligomertoxicityfibriltoxicityandfibrilspreadinginsynucleinopathies